Concepedia

Chonglei Bi

CB

Statistics

Publications

24

Citations

1.5K

H-Index

21

Active since

2008

Affiliations

National University of Singapore(Current)

National University Cancer Institute, Singapore

National University Health System

National University Hospital

Agency for Science, Technology and Research

Chonglei Bi is an author at National University of Singapore specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2008–2021

24

Publications

24

The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML

Jianbiao Zhou, Chonglei Bi, Lip-Lee Cheong et al. · Blood · 2011 · 210 citations · Full text

EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity

Junli Yan, Siok‐Bian Ng, Jim Liang-Seah Tay et al. · Blood · 2013 · 163 citations

Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML

Jianbiao Zhou, Chonglei Bi, Jasinghe V. Janakakumara et al. · Blood · 2009 · 160 citations · Full text

EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma

Junli Yan, Boheng Li, Baohong Lin et al. · Blood · 2016 · 134 citations · Full text

Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma

Siok‐Bian Ng, Junli Yan, Gaofeng Huang et al. · Blood · 2011 · 114 citations

1–5 of 24